A Post Marketing Surveillance on Lutathera® in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor in Korea

NCT04946305 · clinicaltrials.gov ↗

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Somatostatin Receptor-positive GEP-NET

Interventions

OTHER: Lutathera

Sponsor

Novartis Pharmaceuticals